Figure 1.

A: Indirect comparison model and (B) the risk of bias in source studies. With 1 or 2 of 6 domains at high risk of bias, the overall risk of bias for each of these studies was classified as moderate. TBZ, tetrabenazine; DEU, deutetrabenazine.